ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 101 filers reported holding ENDOCYTE INC in Q3 2014. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $72,000 | +125.0% | 47,932 | +277.0% | 0.00% | +100.0% |
| Q4 2016 | $32,000 | -82.0% | 12,713 | -77.9% | 0.00% | -75.0% |
| Q3 2016 | $178,000 | +111.9% | 57,621 | +120.1% | 0.00% | +100.0% |
| Q2 2016 | $84,000 | +78.7% | 26,180 | +73.4% | 0.00% | +100.0% |
| Q1 2016 | $47,000 | -29.9% | 15,099 | -9.4% | 0.00% | 0.0% |
| Q4 2015 | $67,000 | +42.6% | 16,673 | +63.5% | 0.00% | 0.0% |
| Q3 2015 | $47,000 | -68.5% | 10,195 | -64.4% | 0.00% | -66.7% |
| Q2 2015 | $149,000 | +125.8% | 28,620 | +172.5% | 0.00% | +200.0% |
| Q4 2014 | $66,000 | -29.8% | 10,502 | -32.5% | 0.00% | -50.0% |
| Q3 2014 | $94,000 | -68.8% | 15,565 | +22.9% | 0.00% | -50.0% |
| Q1 2014 | $301,000 | – | 12,660 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,364,648 | $14,401,000 | 1.20% |
| Asymmetry Capital Management, L.P. | 81,484 | $349,000 | 0.47% |
| PFM Health Sciences, LP | 3,441,594 | $14,730,000 | 0.35% |
| Perceptive Advisors | 1,451,700 | $6,213,000 | 0.21% |
| Leisure Capital Management | 28,304 | $121,000 | 0.10% |
| Cribstone Capital Management, LLC | 47,349 | $203,000 | 0.10% |
| EAM Investors, LLC | 98,034 | $420,000 | 0.08% |
| SG3 Management, LLC | 32,500 | $139,000 | 0.05% |
| Baker Brothers Advisors | 1,087,323 | $4,654,000 | 0.04% |
| Alpine Global Management, LLC | 33,675 | $144,000 | 0.03% |